Financials
Income statement
| Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
|---|---|---|---|---|
| Total reported revenue | 10.1B | 8.3B | 11.2B | 9.4B |
| Cost of revenue | 4.4B | 3.3B | 5.2B | 3.6B |
| Gross profit | 5.7B | 5.0B | 6.1B | 5.8B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 3.0B | 2.6B | -7.1B | 2.8B |
| Operating income | 1.9B | 1.6B | 2B | 2.1B |
| Non operating interest income | ||||
| Income | 41M | 59M | 186M | 83M |
| Expense | 54M | 56M | 188M | 55M |
| Other income expense | — | — | — | — |
| Pretax income | 1.9B | 1.7B | 1.8B | 2.2B |
| Tax provision | 444M | 366M | 405M | 475M |
| Net income | 1.5B | 1.3B | 1.4B | 1.7B |
| Basic EPS | — | 0.4 | — | — |
| Diluted EPS | — | 0.4 | — | — |
| Basic average shares | — | 3.1B | — | — |
| Diluted average shares | — | 3.1B | — | — |
| EBITDA | 2.8B | 2.5B | 2.7B | 3.0B |
| Net income from continuing op. | — | — | — | — |
| Minority interests | 0 | 0 | 0 | -2M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |